The pharmaceutical industry is in constant pursuit of novel molecular structures that can serve as foundations for new therapeutic agents. Among the vast array of organic compounds, imidazole derivatives have consistently demonstrated significant biological activity, making them invaluable in drug discovery and development. 1,1',1'',1''',1'''',1'''''-(1,2,3,4,5,6-benzenehexayl)hexakis-1H-Imidazole (CAS: 148807-16-3), with its unique multivalent imidazole structure, presents a compelling case for its use in medical research.
The intrinsic biological relevance of the imidazole ring system is well-documented. It is a core component in many essential biomolecules, including histidine and histamine, and is found in numerous pharmaceutical drugs targeting a wide range of conditions. The compound in question, with its six strategically placed imidazole groups, offers a rich scaffold for medicinal chemists to explore. Researchers can leverage its structure to design targeted molecules that may interact with specific biological pathways or targets. As a potential drug intermediate, its consistent availability from a reputable supplier is crucial for the continuity of research projects.
When undertaking drug discovery initiatives, the quality and purity of starting materials directly influence the success of synthesis and biological screening. A compound like hexakis-1H-imidazole, sourced from a reliable manufacturer, ensures that the experiments are based on well-defined and pure chemical entities. This precision is vital for establishing clear structure-activity relationships and for ensuring the safety and efficacy of potential drug candidates.
Furthermore, the molecule's potential extends beyond acting as a simple intermediate. Its ability to coordinate with metal ions, as discussed in the context of coordination chemistry, also hints at potential applications in metallodrugs or diagnostic agents. The field of inorganic medicinal chemistry is rapidly expanding, and compounds like this offer a bridge between organic synthesis and metal-based therapeutics.
For institutions and companies engaged in medical research and drug development, identifying a trustworthy source for specialized chemicals is paramount. We understand the stringent requirements of the pharmaceutical sector and are committed to providing high-purity 1,1',1'',1''',1'''',1'''''-(1,2,3,4,5,6-benzenehexayl)hexakis-1H-Imidazole. By partnering with us, you gain access to a quality product from a dedicated chemical manufacturer in China. We encourage you to buy from a source that prioritizes scientific integrity and material excellence. Inquire about our product specifications and sampling options to see how this versatile imidazole derivative can advance your medical research objectives.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.